Denali Therapeutics Inc. (DNLI)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch DNLI
See up to 3 months of DNLI. The 7-day demo opens the 1M and 3M ranges and puts DNLI on your watchlist.
Start 7-day demoLatest DNLI insider trades
About Denali Therapeutics Inc. (DNLI)
The SEC lists Denali Therapeutics Inc. under CIK 0001714899, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
DNLI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 18,718 | $435K |
| Bona-fide gift | 1 | 32,220 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
DNLI insider transactions (Form 4)
6430 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peter Scott Chin - Officer | Open-market sale | Common Stock | 1,654 | $22.29 footnote F2 | $37K | |
| ||||||
| Nancy Thornberry - Director | Open-market sale | Common Stock | 10,824 | $22.85 footnote F2 | $247K | |
| Nancy Thornberry - Director | Open-market sale | Common Stock | 615 | $23.74 footnote F4 | $15K | |
| ||||||
| Alexander O. Schuth - Officer | Open-market sale | Common Stock | 2,768 | $23.44 | $65K | |
| Ryan J. Watts - Officer | Gift | Common Stock | 32,220 footnote F1 | $0.00 | - | |
| ||||||
| Alexander O. Schuth - Officer | Open-market sale | Common Stock | 2,857 | $25.07 | $72K | |
 Jay T. Flatley - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| Jay T. Flatley - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
| Peter S. Klein - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| Peter S. Klein - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
 Steve E. Krognes - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| Steve E. Krognes - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
| David P. Schenkein - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| David P. Schenkein - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
| Nancy Thornberry - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| Nancy Thornberry - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
| Hauwermeiren Timothy van - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| Hauwermeiren Timothy van - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
| Jennifer E. Cook - Director | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| Jennifer E. Cook - Director | Grant or award | Stock Option (right to buy) | 19,226 | $0.00 | - | |
| ||||||
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 6,408 footnote F1 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 19,226 footnote F10 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 19,226 footnote F10 | $0.00 | - | |
| ||||||
| Hauwermeiren Timothy van - Director | Grant or award | Common Stock | 10,632 footnote F1 | $0.00 | - | |
| Hauwermeiren Timothy van - Director | Grant or award | Stock Option (right to buy) | 31,897 | $0.00 | - | |
| ||||||
| Ryan J. Watts - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Alexander O. Schuth - Officer | Open-market sale | Common Stock | 2,937 | $13.58 | $40K | |
| Carole Ho - Officer | Open-market sale | Common Stock | 2,937 | $13.58 | $40K | |
| Carole Ho - Officer | Open-market sale | Common Stock | 806 | $14.64 | $12K | |
| Carole Ho - Officer | Option exercise | Common Stock | 44,655 | $0.68 | $30K | |
| Carole Ho - Officer | Option exercise | Stock Option (right to buy) | 44,655 | $0.00 | - | |
| Ryan J. Watts - Officer | Option exercise | Common Stock | 455,282 | $0.68 | $310K | |
| Ryan J. Watts - Officer | Option exercise | Common Stock | 40,000 | $5.28 | $211K | |
| Ryan J. Watts - Officer | Open-market sale | Common Stock | 495,282 | $15.00 | $7.43M | |
| Ryan J. Watts - Officer | Option exercise | Stock Option (right to buy) | 455,282 | $0.00 | - | |
| Ryan J. Watts - Officer | Option exercise | Stock Option (right to buy) | 40,000 | $0.00 | - | |
| Jay T. Flatley - Director | Grant or award | Common Stock | 6,037 | $0.00 | - | |
| Jay T. Flatley - Director | Grant or award | Stock Option (right to buy) | 18,111 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 10,565 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 10,565 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy)uy) | 31,695 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 31,695 | $0.00 | - | |
| Alexander O. Schuth - Officer | Option exercise | Common Stock | 6,708 | $5.28 | $35K | |
| Alexander O. Schuth - Officer | Option exercise | Stock Option (right to buy) | 6,708 | $0.00 | - | |
| Carole Ho - Officer | Option exercise | Common Stock | 17,845 | $0.68 | $12K | |
| Carole Ho - Officer | Option exercise | Stock Option (right to buy) | 17,845 | $0.00 | - | |
| Alexander O. Schuth - Officer | Option exercise | Common Stock | 20,516 | $0.68 | $14K | |
| Alexander O. Schuth - Officer | Option exercise | Stock Option (right to buy) | 20,516 | $0.00 | - | |
| David P. Schenkein - Director | Option exercise | Common Stock | 47,165 | $18.00 | $849K | |
| David P. Schenkein - Director | Open-market sale | Common Stock | 27,129 | $32.09 | $871K | |
| David P. Schenkein - Director | Open-market sale | Common Stock | 32,312 | $32.87 | $1.06M | |
| David P. Schenkein - Director | Option exercise | Stock Option (right to buy) | 47,165 | $0.00 | - | |
| Alexander O. Schuth - Officer | Option exercise | Common Stock | 15,558 | $5.28 | $82K | |
| Alexander O. Schuth - Officer | Open-market sale | Common Stock | 12,333 | $29.68 | $366K | |
| Alexander O. Schuth - Officer | Open-market sale | Common Stock | 2,925 | $30.72 | $90K | |
| Alexander O. Schuth - Officer | Open-market sale | Common Stock | 300 | $31.29 | $9K | |
| Alexander O. Schuth - Officer | Option exercise | Stock Option (right to buy) | 15,558 | $0.00 | - | |
 Vicki L. Sato - Director | Open-market sale | Common Stock | 1,020 | $30.00 | $31K | |
| Vicki L. Sato - Director | Open-market sale | Common Stock | 3,080 | $27.07 | $83K | |
| Ryan J. Watts - Officer | Option exercise | Common Stock | 40,000 | $0.68 | $27K | |
| Ryan J. Watts - Officer | Open-market sale | Common Stock | 40,000 | $27.69 | $1.11M | |
| Ryan J. Watts - Officer | Option exercise | Stock Option (right to buy) | 40,000 | $0.00 | - | |
| Steve E. Krognes - Director | Open-market sale | Common Stock | 30,000 | $29.03 | $871K | |
Item 2.02, 9.01
Item 2.01, 9.01
Item 1.01, 7.01, 9.01
Item 5.07, 9.01
Recent DNLI Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Chin Peter Scott | Officer | 1,654 | $37K | View on EDGAR | |
| NANCY THORNBERRY | Director | 11,439 | $266K |
DNLI insider trading FAQ
What is the latest insider trade for DNLI?
Denali Therapeutics Inc. (DNLI) had 5 insider filings in the last 90 days, with the most recent on 2026-09-09. The full record for DNLI runs to 30 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DNLI stock?
No insider purchases of DNLI were filed in the last 90 days.
How many insiders are selling DNLI stock?
5 insider sales of DNLI were filed in the last 90 days, totaling $435K.
Where can I see DNLI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DNLI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Peter Scott Chin view on EDGAR
- - Nancy Thornberry view on EDGAR
- - Alexander O. Schuth view on EDGAR
- - Ryan J. Watts view on EDGAR
- - Alexander O. Schuth view on EDGAR
- - Jay T. Flatley view on EDGAR
- - Peter S. Klein view on EDGAR
- - Steve E. Krognes view on EDGAR
- - David P. Schenkein view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where DNLI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DNLI with a 7-day demo
- DNLI on your watchlist
- Every DNLI Form 4 filing on record
- Up to 3 months of DNLI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
